(HealthDay)—Implementation of a guideline can reduce nonindicated use of proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) among newborns, according to a study published online Nov. 21 in Pediatrics.
Nov 22, 2017
0
0
Long-term proton pump inhibitor (PPI) use does not increase the risk of hip fracture among persons with Alzheimer's disease, according to a new study from the University of Eastern Finland. The risk of hip fracture was slightly ...
Mar 13, 2018
0
2
A new white paper by the American Foregut Society (AFS) summarizes the published outcome data for Transoral Incisionless Fundoplication 2.0 (TIF 2.0) and Concomitant Transoral Incisionless Fundoplication (cTIF) to date and ...
May 23, 2023
0
0
